methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, R...

FDA Drug Recall #D-0299-2026 — Class II — January 15, 2026

Recall Summary

Recall Number D-0299-2026
Classification Class II — Moderate risk
Date Initiated January 15, 2026
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Greenstone Llc
Location Peapack, NJ
Product Type Drugs
Quantity 3456 cartons

Product Description

methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2

Reason for Recall

Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.

Distribution Pattern

Nationwide within the United States

Lot / Code Information

Lot # LG7675, Exp. Date Nov 2026

Other Recalls from Greenstone Llc

Recall # Classification Product Date
D-1361-2014 Class I Venlafaxine HCl Extended-Release Capsules, 150 ... Mar 6, 2014
D-746-2014 Class II sertraline HCl tablets, 25 mg, 30 Tablets, Rx o... Nov 5, 2013
D-1059-2014 Class III Glipizide XL (glipizide) extended release table... Nov 4, 2013
D-737-2014 Class II Nifedipine, extended-release tablets, 90mg 100 ... Nov 1, 2013
D-010-2014 Class II Spironolactone tablets, USP 25 mg, Rx only, 500... Sep 4, 2013

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.